Key Financial Figures (in INR Lakhs)

Revenue from Operations: 2,301.03 (FY26) vs 2,264.68 (FY25)

Other Income: 226.91 (FY26) vs 333.86 (FY25)

Total Income: 2,527.94 (FY26) vs 2,598.54 (FY25)

Total Expenses: 2,191.90 (FY26) vs 2,304.19 (FY25)

Profit Before Exceptional Items and Tax: 336.04 (FY26) vs 294.34 (FY25)

Exceptional Items: (59.57) (FY26) vs (92.63) (FY25)

Profit Before Tax: 395.61 (FY26) vs 386.97 (FY25)

Tax Expenses: 61.71 (FY26) vs 60.37 (FY25)

Profit for the Year: 333.89 (FY26) vs 326.61 (FY25)

Operational Highlights

  • Multi-specialty hospital with 150 beds including 65 ICU beds
  • Located in Gandhinagar, Gujarat, established in 2012
  • Facilities include cardiac OTs, endoscopy procedure rooms, Cath Lab, CT scan
  • Advanced infrastructure with laminar airflow, HEPA filters, pneumatic transfer system
  • 235 employees on rolls during reporting period

Corporate Governance

Board Composition:

  • Mr. Bipinchandra D. Shah (Chairman & Managing Director)
  • Mrs. Shreyarthi B. Shah (Director)
  • Mr. Jigar K. Trivedi (Independent Director)
  • Mr. Umang A. Shah (Independent Director)

Key Managerial Personnel:

  • Mr. Lokesh Khandelwal (Chief Financial Officer)
  • Mr. Mayank Agarwal (Company Secretary)

Committee Composition:

  • Audit Committee: Mr. Umang A. Shah (Chairman), Mr. Jigar K. Trivedi, Mrs. Shreyarthi B. Shah
  • Nomination & Remuneration Committee: Mr. Umang A. Shah (Chairman), Mr. Jigar K. Trivedi, Mrs. Shreyarthi B. Shah
  • Stakeholders Relationship Committee: Mr. Umang A. Shah (Chairman), Mr. Bipinchandra D. Shah, Mrs. Shreyarthi B. Shah

Auditor Appointments

Statutory Auditors: M/s. Parimal S Shah & Co., Chartered Accountants (FRN: 107591W) appointed for 5 years till conclusion of 16th AGM

Secretarial Auditor: M/s. Suthar & Surti, Company Secretaries

Internal Auditor: M/s. S C Bohara & Associates, Chartered Accountants

Capital Structure

Authorized Share Capital: ₹25,00,00,000 (2,50,00,000 equity shares of ₹10 each)

Issued Capital: ₹23,40,00,000 (2,34,00,000 equity shares of ₹10 each)

Subscribed & Paid-up Capital: ₹23,40,00,000 (2,34,00,000 equity shares of ₹10 each)

Significant Financial Ratios

Debtors Turnover Ratio: 3.94 (FY26) vs 4.75 (FY25)

Inventory Turnover Ratio: 9.35 (FY26) vs 9.40 (FY25)

Interest Coverage Ratio: 6.36 (FY26) vs 4.41 (FY25) - improved 44.22%

Current Ratio: 2.80 (FY26) vs 1.29 (FY25) - improved 117.49%

Debt Equity Ratio: 0.06 (FY26) vs 0.07 (FY25)

Operating Profit Margin: 18.43% (FY26) vs 33.61% (FY25) - decreased 45.16%

Net Profit Margin: 14.51% (FY26) vs 14.42% (FY25)

Return on Net Worth: 3.29% (FY26) vs 5.05% (FY25) - decreased 34.85%

Managerial Remuneration

Mr. Bipinchandra D. Shah (CMD): ₹1,44,00,000 (ratio to median remuneration 0.01:1)

Mr. Mayank Agarwal (CS): 7.70% increase in remuneration

Mr. Lokesh Khandelwal (CFO): 6.06% increase in remuneration

Borrowings and Security

Secured Loans from Bank of India:

  • Term Loan: ₹13,253,624 (A/c No. 64)
  • Term Loan against Residential Property: ₹42,723,906
  • Cash Credit: ₹21,322,921 (A/c No. 112)

Security Provided:

  • Hypothecation of Plant & Machinery, Stock & Book Debts
  • Equitable Mortgage of Hospital Land & Building at Sargasan, Gandhinagar
  • Equitable Mortgage of property at Dharmoda, Tal Chanasma, Dist Patan
  • Equitable Mortgage of residential property at Ahmedabad

Related Party Transactions

All transactions with related parties were in ordinary course of business and at arm's length basis. Material transaction: Ms. Aashna Bipin Shah (daughter of promoters) appointed to place of profit, approved by Board on 30-May-2024.

Corporate Actions

  • No dividend recommended for FY26
  • No amount transferred to Investor Education and Protection Fund
  • No material changes or commitments affecting financial position
  • No frauds reported by auditors

AGM Details

14th Annual General Meeting: September 24, 2026 at 11:30 am

Venue: Between Sargasan & Reliance Cross Road, Sargasan, Gandhinagar - 382421

Business to be transacted:

1. Adoption of Financial Statements

2. Re-appointment of Mr. Bipinchandra D. Shah as Director retiring by rotation

3. Special Resolution: Re-appointment of Mr. Bipinchandra D. Shah as Chairman & Managing Director for 3 years with remuneration of ₹10 lakhs per month basic plus perquisites

4. Special Resolution: Increase borrowing limit to ₹25 crore under Section 180(1)(c)

5. Special Resolution: Authorize investments/loans/guarantees up to ₹50 crore under Section 186

Secretarial Audit Report

Clean report from Suthar & Surti, Company Secretaries confirming compliance with:

  • Companies Act, 2013 and rules thereunder
  • SEBI Listing Regulations
  • Other applicable laws including healthcare regulations
  • Secretarial Standards SS-1 and SS-2

#Tags: #AashkaHospitals #AnnualReport #SEBIDisclosure #FinancialResults #Healthcare